genOway S.A.
ALGEN.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €35,558 | €41,520 | €35,281 | €37,855 |
| - Cash | €4,953 | €4,260 | €4,880 | €5,605 |
| + Debt | €5,575 | €7,233 | €9,046 | €10,825 |
| Enterprise Value | €36,181 | €44,493 | €39,448 | €43,075 |
| Revenue | €22,059 | €20,046 | €17,053 | €14,019 |
| % Growth | 10% | 17.6% | 21.6% | – |
| Gross Profit | -€1,885 | €18,804 | -€1,310 | -€3,746 |
| % Margin | -8.5% | 93.8% | -7.7% | -26.7% |
| EBITDA | €3,894 | €6,351 | €537 | -€1,878 |
| % Margin | 17.7% | 31.7% | 3.1% | -13.4% |
| Net Income | €1,831 | €1,568 | €778 | -€323 |
| % Margin | 8.3% | 7.8% | 4.6% | -2.3% |
| EPS Diluted | 0.2 | 0.17 | 0.088 | -0.037 |
| % Growth | 17.6% | 92.7% | 341% | – |
| Operating Cash Flow | €5,382 | €3,063 | €2,355 | -€561 |
| Capital Expenditures | -€2,388 | -€1,783 | -€1,917 | -€2,276 |
| Free Cash Flow | €2,994 | €1,280 | €439 | -€2,837 |